08.07.2020 • NewsCortevaElaine Burridgeagroscience

Corteva Takes Control of PhytoGen Seed

Corteva Agriscience has agreed to take over J.G. Bosell’s stake in their joint-venture company PhytoGen Seed Co. Financial terms of the deal were not disclosed.

PhytoGen Seed was formed in 1998 to focus on the US cottonseed industry with one of Corteva’s predecessors, Dow AgroSciences, owning a 53.5% stake. More recently, Corteva has operated the jv in the US market through wholly owned subsidiary Mycogen.

“This acquisition provides a solid proof point of our consistent commitment to driving long-term growth through targeted investments in solid margin opportunities that at the same time strengthen our ability to serve our customers,” said James Collins, Jr,  CEO of Corteva Agriscience.

Steve Reno, president of the Corteva Seed Business Platform, added: “This step further strengthens Corteva Agriscience’s commitment to the cotton market – and positions the Company well to diversify and grow this business globally over time.”

Corteva said the PhytoGen portfolio, including PhytoGen Breeding Traits, PhytoGen varieties with both the Enlist cotton trait and WideStrike and WideStrike 3 insect protection, is well suited to help farmers protect their crops from potential yield-robbing pests.

Corteva Agriscience has agreed to take over J.G. Bosell’s stake in their...
Corteva Agriscience has agreed to take over J.G. Bosell’s stake in their joint-venture company PhytoGen Seed Co. Owning a 53.5% stake. Corteva has operated the jv in the US market through wholly owned subsidiary Mycogen. Financial terms were not disclosed. (c) Corteva

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.